OP-DAPA TRIO
OP-DAPA TRIO is a pharmaceutical product/formulation containing Dapagliflozin 10 mg + Sitagliptin 100 mg + Metformin 500 mg (SR). It is part of the Optalogic Pharma portfolio of diabetes-focused products.
| Ingredient | Strength |
|---|---|
| Dapagliflozin | 10 mg |
| Sitagliptin | 100 mg |
| Metformin | 500 mg(SR) |
Product Information
For complete prescribing information, dosage, administration, contraindications, warnings, and precautions, please refer to the approved product literature and consult a qualified healthcare professional.
Important Disclaimer
This product information is intended for healthcare professionals and general informational purposes. It is not a substitute for professional medical advice, diagnosis, or treatment. Products should be used only as directed by a qualified healthcare professional.
